Difference between revisions of "Team:Hong Kong-CUHK/Notebook"

Line 1: Line 1:
 
{{Hong_Kong-CUHK}}
 
{{Hong_Kong-CUHK}}
 
<html>
 
<html>
 +
<head>
 +
<style>
 +
#myDIV {
 +
    width: 100%;
 +
    padding: 50px 0;
 +
    text-align: center;
 +
    background-color: lightblue;
 +
    margin-top:20px;
 +
}
 +
</style>
 +
</head>
 +
<body>
 
April 2016
 
April 2016
 
<ul>
 
<ul>
Line 40: Line 52:
 
<li style="margin-left: 24.0pt; text-indent: -24.0pt;">Continued fundraising.</li>
 
<li style="margin-left: 24.0pt; text-indent: -24.0pt;">Continued fundraising.</li>
 
</ul>
 
</ul>
 +
</body>
 
<script>
 
<script>
 
function myFunction() {
 
function myFunction() {

Revision as of 13:57, 10 August 2017

April 2016
  • Settlement of lab duties and position.
  • Lab safety Training.
  • Started regular meetings every week.
May 2016
  • Recruitment of ideas and prepare preliminary data for selection.
  • Project related to pancreatic cancer diagnosis by Toehold Switch is selected

August 2016

  • Cloning of switches and itscorresponding triggers into pSB1A2 and pSB1 with significant “ON/OFF”ratio in vivo.

 

September 2016

  • Identified problems to design Toehold Switch manually and outline programme functions for semi-automatic toehold switch design.
  • Modified the switch by using new chromoprotein (amajLime and amilCP) by traditional cloning method to produce intuitive readout.

 

October 2016

  • Reviewing the impact and necessity of technology in nowadays society, we decided to use Toehold Switch to subtype Influenza A.

November 2016

  • Brainstorming and literature reviewing on how to maximize the“ON/OFF” ratio of Toehold switch.
  • Constructed programs which embedded with Influenza A sequence database and Vienna RNA package.

December 2016

  • Failed to test the system in cell free system due to insufficient materials and resources.
  • T7-rna-polymerase amplification system is cloning to yield higher “ON/OFF”
  • Requested for sponsorship.
  • Skyped the Pakistan iGEM team to explore the potential of collaboration.
  • Continued fundraising.